Home » Topics » BioWorld

BioWorld
RSS

BURROUGHS EXTENDS CYTRX LICENSE

April 16, 1991

GLYCOMED FILES FOR 2.3 MILLION-SHARE IPO

April 16, 1991

IMMUNOMEDICS FILES PLA FOR CANCER DIAGNOSTIC

April 16, 1991

CETUS AND ERBAMONT SETTLE CANCER DRUG DISPUTE

April 16, 1991

NEWS BRIEFS

April 15, 1991

CEO READY TO TAKE ALKERMES TO MARKET

April 15, 1991

JOURNAL SCAN PUTATIVE ONCOGENE IDENTIFIED

April 15, 1991

FDA APPROVES DIGENE'S HPV TYPING KIT

April 15, 1991

ECOGEN LICENSES GENES TO PIONEER

April 15, 1991

APPOINTMENTS AND ADVANCEMENTS

April 15, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Sex differences shape gene activity across the human brain
BioWorld
Genes that are switched on or off in the human brain differ between men and women. Moreover, these differences are not uniform. They vary across cortical regions...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
Gilead Sciences patents new GTPase KRAS G12D inhibitors
BioWorld Science
Gilead Sciences Inc. has disclosed new GTPase KRAS G12D mutant inhibitors potentially useful for the treatment of cancer.